ResearcherFudan UniversityActive in the last 2 years

Wei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7614-4436; OpenAlex author ID A5026818586. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 2 papers

Papers 2

Qingyihuaji formula reprograms metabolism to suppress pancreatic cancer growth and progression through LINC00346-OMA1-ATF4 signaling. Last author DOI 10.1016/j.jep.2025.119893 ↗
DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms26167731 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weidong Shi · 1 shared paper, 2025 · strength 0.30
- Paper Qingyihuaji formula reprograms metabolism to suppress pancreatic cancer growth and progression through LINC00346-OMA1-A… DOI 10.1016/j.jep.2025.119893 ↗
Li Ye · 1 shared paper, 2025 · strength 0.24
- Paper DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ducta… DOI 10.3390/ijms26167731 ↗
Yi Zhun Zhu · 1 shared paper, 2025 · strength 0.24
- Paper DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ducta… DOI 10.3390/ijms26167731 ↗
Xuan Huang · 1 shared paper, 2025 · strength 0.24
- Paper DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ducta… DOI 10.3390/ijms26167731 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.